Sanara MedTech Inc. — Director's Dealing 2022

Mar 10, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2022-03-08

Reporting Person: Fleming Zachary B. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-08	Common Stock	A	8831	—	Acquired	39770	Direct

Footnotes

F1: Represents shares of restricted stock granted to the reporting person pursuant to the Sanara MedTech Inc. 2014 Omnibus Long-Term Incentive Plan, as amended and restated. The restricted stock will vest in three equal installments, with one-third of the shares vesting on March 1, 2023, 2024 and 2025, respectively.